Horst Lorenz

509 total citations
22 papers, 300 citations indexed

About

Horst Lorenz is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Horst Lorenz has authored 22 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in Horst Lorenz's work include Platelet Disorders and Treatments (4 papers), Dialysis and Renal Disease Management (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Horst Lorenz is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Dialysis and Renal Disease Management (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Horst Lorenz collaborates with scholars based in Germany, Switzerland and Austria. Horst Lorenz's co-authors include M. Verho, B Rangoonwala, Vincent Esnault, F Cantarovich, Folker Wenzel, Peter Gerke, G. Schöck, Rainer N. Zahlten, B. Tutschek and Uwe Karsten and has published in prestigious journals such as American Journal of Kidney Diseases, Clinica Chimica Acta and Nephrology Dialysis Transplantation.

In The Last Decade

Horst Lorenz

22 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Horst Lorenz Germany 8 151 70 58 45 40 22 300
Roberto Giacosa Italy 11 143 0.9× 76 1.1× 35 0.6× 26 0.6× 35 0.9× 15 401
Thomas Karvunidis Czechia 10 143 0.9× 56 0.8× 151 2.6× 67 1.5× 46 1.1× 29 340
Katrín Þormar Denmark 12 66 0.4× 73 1.0× 125 2.2× 89 2.0× 29 0.7× 20 303
M. Beaman United Kingdom 11 202 1.3× 58 0.8× 58 1.0× 13 0.3× 46 1.1× 23 356
Dingwei Kuang China 10 208 1.4× 60 0.9× 33 0.6× 39 0.9× 96 2.4× 16 405
Anne Sophie Bargnoux France 9 68 0.5× 42 0.6× 56 1.0× 12 0.3× 55 1.4× 20 276
Gary R. Haynes United States 9 48 0.3× 125 1.8× 64 1.1× 150 3.3× 30 0.8× 16 322
Mariely Nieves-Plaza Puerto Rico 8 77 0.5× 53 0.8× 90 1.6× 14 0.3× 34 0.8× 19 328
Laura Fuiano Italy 9 78 0.5× 47 0.7× 31 0.5× 9 0.2× 24 0.6× 18 231
Andrea Breglia Italy 8 107 0.7× 64 0.9× 103 1.8× 55 1.2× 24 0.6× 12 347

Countries citing papers authored by Horst Lorenz

Since Specialization
Citations

This map shows the geographic impact of Horst Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horst Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horst Lorenz more than expected).

Fields of papers citing papers by Horst Lorenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Horst Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horst Lorenz. The network helps show where Horst Lorenz may publish in the future.

Co-authorship network of co-authors of Horst Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Horst Lorenz. A scholar is included among the top collaborators of Horst Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Horst Lorenz. Horst Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egli-Spichtig, Daniela, Markus Ketteler, Andrzej Więcek, et al.. (2023). Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients. Clinical Kidney Journal. 16(10). 1622–1633. 5 indexed citations
2.
Ketteler, Markus, Andrzej Więcek, Alexander R. Rosenkranz, et al.. (2022). Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trial. Nephrology Dialysis Transplantation. 38(4). 982–991. 8 indexed citations
4.
5.
Giers, G., et al.. (2010). Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion. Haematologica. 95(11). 1921–1926. 15 indexed citations
6.
Giers, G., et al.. (2010). Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts. Vox Sanguinis. 99(4). 348–353. 5 indexed citations
7.
Giers, G., et al.. (2009). Retrospective comparison of maternal vs. HPA‐matched donor platelets for treatment of fetal alloimmune thrombocytopenia. Vox Sanguinis. 98(3p2). 423–430. 6 indexed citations
8.
Cantarovich, F, B Rangoonwala, Horst Lorenz, M. Verho, & Vincent Esnault. (2004). High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. American Journal of Kidney Diseases. 44(3). 402–409. 98 indexed citations
9.
Cantarovich, F, B Rangoonwala, Horst Lorenz, M. Verho, & Vincent Esnault. (2004). High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. American Journal of Kidney Diseases. 44(3). 402–409. 65 indexed citations
10.
Lorenz, Horst, et al.. (1998). Effects of Felodipine ER, a Dihydropyridine Calcium Antagonist, on Blood Pressure and Serum Lipids. Current Medical Research and Opinion. 14(2). 97–103. 3 indexed citations
11.
Lewicka, S., D. Haack, Horst Lorenz, et al.. (1994). Role of 21-deoxyaldosterone in human hypertension. The Journal of Steroid Biochemistry and Molecular Biology. 50(5-6). 319–327. 3 indexed citations
12.
Jennings, Russell W., N. Scott Adzick, Michael T. Longaker, Horst Lorenz, & M R Harrison. (1993). Radiotelemetric fetal monitoring during and after open fetal operation. International Journal of Gynecology & Obstetrics. 42(3). 327–327. 7 indexed citations
14.
Verho, M., et al.. (1988). Absence of crystalluria and estimation of renal parameters after oral and intravenous ofloxacin as compared to placebo in healthy volunteers.. PubMed. 14(8). 539–45. 5 indexed citations
15.
Verho, M., V. Malerczyk, G. Kauert, & Horst Lorenz. (1988). Dose linearity and relative bioavailability testing of oxilofrine, a sympathicomimetic drug, in healthy volunteers.. PubMed. 8(3). 211–5. 5 indexed citations
16.
Lorenz, Horst, et al.. (1986). The Age Dependency of the Creatinine-Related Concentration of Ribonucleosides in Human Urine. Clinical Chemistry and Laboratory Medicine (CCLM). 24(12). 993–9. 2 indexed citations
17.
Lorenz, Horst, et al.. (1983). Multivariate Analysis of Urinary RNA Catabolites in Malignancies: Cross-Sectional and Longitudinal Studies. PubMed. 84. 317–330. 5 indexed citations
19.
Schöch, G, et al.. (1977). [Excretion of nucleic degradation products in relation to age and growth].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 125(5). 542–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026